Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AstraZeneca PLC    AZN

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo AstraZeneca PLC
AstraZeneca is one of the world's leading pharmaceutical groups. Net sales break down by treatment area as follows:

- cardiovascular, renal and metabolic diseases (31.9%);

- oncology (28.6%);

- respiratory diseases (23.3%);

- other (16.2%): inflammatory and autoimmune diseases, neurological diseases, gastrointestinal and infectious diseases.

The remaining sales (4.7%) concern primarily research and study services provided for third parties.

Net sales are distributed geographically as follows: the United Kingdom (10.8%), Continental Europe (17.3%), Americas (38.6%) and Africa/Asia/Australia (33.3%).
Sales per Businesses
20172018Delta
USD (in Million)%USD (in Million)%
Cardiovascular, Renal & Metabolism7,26632%6,71030.4% -7.65%
Respiratory4,70620.7%4,91122.3% +4.36%
Other Diseases4,15618.3%3,40015.4% -18.19%
Oncology4,02417.7%6,02827.3% +49.8%
Externalisation Revenue2,31310.2%1,0414.7% -54.99%
Sales per Regions
20172018Delta
USD (in Million)%USD (in Million)%
United States6,66629.4%7,24032.8% +8.61%
United Kingdom3,24014.3%2,39010.8% -26.23%
China2,95513%3,77817.1% +27.85%
Japan2,1729.6%1,9528.9% -10.13%
Other Continental Europe1,5126.7%1,3125.9% -13.23%
Other Asia, Africa and Australasia1,2075.3%1,3085.9% +8.37%
Sweden842.003.7%477.002.2% -43.35%
Other Americas809.003.6%806.003.7% -0.37%
France701.003.1%617.002.8% -11.98%
Germany541.002.4%592.002.7% +9.43%
Italy514.002.3%426.001.9% -17.12%
Canada482.002.1%483.002.2% +0.21%
Spain447.002%396.001.8% -11.41%
Australia377.001.7%313.001.4% -16.98%
Managers
NameAgeSinceTitle
Pascal Soriot592012Chief Executive Officer & Executive Director
Leif Johansson682012Non-Executive Chairman
Pam Cheng482015Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer672013Chief Financial Officer & Executive Director
Marcus Wallenberg631999Independent Non-Executive Director
Graham Chipchase562019Senior Independent Non-Executive Director
Geneviéve B. Berger, Dr.642012Independent Non-Executive Director
Philip Arthur John Broadley582017Non-Executive Director
Nazneen Rahman, Dr.-2017Non-Executive Director
Sherilyn S. McCoy602017Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 1,312,137,976 1,255,954,094 95.7% 0 0.0% 95.7%
Shareholders
NameEquities%
Investor AB (Investment Company) 144,008,120 11.0%
Capital Research & Management Co. (World Investors) 54,590,782 4.16%
Wellington Management Co. LLP 44,759,495 3.41%
BlackRock Investment Management (UK) Ltd. 44,717,199 3.41%
The Vanguard Group, Inc. 38,553,000 2.94%
Norges Bank Investment Management 29,622,000 2.26%
Legal & General Investment Management Ltd. 29,425,000 2.24%
BlackRock Fund Advisors 23,326,215 1.78%
Fidelity Management & Research Co. 21,415,000 1.63%
Capital Research & Management Co. (Global Investors) 16,653,000 1.27%
Holdings
NameEquities%Valuation
AstraZeneca Pharma India Limited (506820) 18,750,00075.0%697,684,125 USD
Viela Bio, Inc. (VIE) 14,650,33428.7%576,490,643 USD
Moderna, Inc. (MRNA) 25,499,3257.65%522,991,156 USD
Swedish Orphan Biovitrum (SOBI) 24,193,0928.06%432,097,816 USD
Innate Pharma (IPH) 6,260,5007.97%43,951,527 USD
Circassia Pharmaceuticals plc (CIR) 71,081,21718.9%25,954,596 USD
PhaseBio Pharmaceuticals, Inc. (PHAS) 3,004,55410.4%14,962,679 USD
Entasis Therapeutics Holdings Inc. (ETTX) 2,164,85516.3%10,824,275 USD
Aevi Genomic Medicine, Inc. 12,946,90016.7%2,395,177 USD
Company contact information
AstraZeneca Plc
Cambridge Biomedical Campus
1 Francis Crick Avenue
Cambridge, Cambridgeshire CB2 0AA

Phone : +44.20.3749.5000
Fax : +44.12.2335.2858
Web : http://astrazeneca.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ASTRAZENECA PLC-4.59%124 604
JOHNSON & JOHNSON0.03%381 112
ROCHE HOLDING AG5.13%287 430
MERCK AND COMPANY-11.74%204 366
NOVARTIS-5.57%201 414
PFIZER-11.51%187 773
NOVO NORDISK AS8.92%144 260
BRISTOL-MYERS SQUIBB COMPANY-0.34%140 282
ABBVIE INC.0.72%131 911
ASTRAZENECA PLC-4.05%124 604
AMGEN INC.-9.62%124 084
SANOFI0.92%123 385
ELI LILLY AND COMPANY3.03%122 733
GLAXOSMITHKLINE-9.94%103 733
BAYER AG-4.15%74 590
ALLERGAN PLC3.66%63 738
CHUGAI PHARMACEUTICAL CO., LTD.0.93%59 643
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.09%57 534
JIANGSU HENGRUI MEDICINE CO., LTD.0.90%55 441
DAIICHI SANKYO COMPANY, LIMITED-0.82%42 780
ASTELLAS PHARMA INC.0.77%30 784
Connections : AstraZeneca PLC